FDA Clearance: LBPs to Treat Parkinson’s Disease

FDA Clearance: LBPs to Treat Parkinson’s Disease

4D pharma plc announced that the FDA has cleared IND applications for two Live Biotherapeutics (LBPs), MRx0005 and MRx0029, for the treatment of Parkinson’s disease. Parkinson’s disease, which impacts more than 10 million people worldwide, is a progressive...